Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 15 |
| Active Pipeline (Recruiting Now) | 15 (5) |
| Completed vs Stopped Early | 0 / 0 (0.0%) |
| Median Closed Actual Enrollment | 274 participants |
| Physical Hospital Site Disclosure | 75.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Gan & Lee Pharmaceuticals Interactive Dossier, benchmark peers in Endocrinology, Obesity, and Metabolic, or review the Healthcare Price & Patent Cliff Crosswalk.